Latest Market News

Nickel Industries delivered its strongest quarterly earnings since late 2023, propelled by a 222% jump in ore sales and significant margin improvements across its nickel processing operations amid favourable regulatory changes and rising nickel prices.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Cleo Diagnostics (ASX:COV) has hit a major milestone by completing sample collection for its pivotal U.S. ovarian cancer trial, while progressing manufacturing and analytical validation steps toward FDA 510(k) submission.

Neometals Ltd has launched a 1-for-6 entitlement offer at A$0.04 per share alongside a two-tranche placement, targeting a combined A$13 million to advance gold and critical minerals projects.

Metal Bank is pushing towards near-term gold production in Western Australia and expanding its critical minerals footprint in Queensland, backed by new processing partnerships and exploration milestones.

Alma Metals has launched an extensive drilling campaign at its Briggs Copper Project in Queensland, aiming to upgrade and grow its 2 million tonne copper resource ahead of pre-feasibility studies.

Culpeo Minerals has restructured its Lana Corina earn-in deal to slash near-term cash outlays and plans a fully funded 4,000m diamond drilling campaign at Vista Montana in Q2 2026, while advancing its Fortuna copper project and streamlining its shareholder base.

Victory Metals has reported record rare earth oxide grades and exceptional metallurgical results at its North Stanmore project, alongside strategic partnerships and heritage clearances that unlock exploration potential.

Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.

Zeotech pushed forward its AusPozz™ metakaolin commercialisation with extended and new MOUs, progressed key Toondoon project approvals amid rising contractor costs, and launched live methane control trials.

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.

Nimy Resources has identified significant extensions to its high-grade gallium deposit at Mons Block 3 and shipped test material to the US as part of a strategic partnership. A scoping study is underway to evaluate mining and processing economics, while regional exploration continues across multiple targets.